BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7250398)

  • 21. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antiprogesterone, prostaglandin analogues and the early interruption of pregnancy].
    Maria B
    Rev Fr Gynecol Obstet; 1990 Apr; 85(4):238-42. PubMed ID: 2195626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Termination of pregnancy in the 2nd trimester using intra-amniotic administration of prostaglandins].
    Krofta L; Calda P; Zizka Z; Parízek A; Hrusková H; Kapras J
    Ceska Gynekol; 1998 Oct; 63(5):414-7. PubMed ID: 9818502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical abortion at first trimester of pregnancy with misoprostol.
    Ayati S; Roudsari FV; Khadem N; Shakeri MT
    Saudi Med J; 2008 Dec; 29(12):1739-42. PubMed ID: 19082224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Termination of second trimester pregnancy with a long-acting vaginal pessary containing 15-methyl-PGF2 alpha methyl ester.
    Int J Gynaecol Obstet; 1983 Apr; 21(2):159-65. PubMed ID: 6136437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral misoprostol vs. vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second-trimester.
    Fadalla FA; Mirghani OA; Adam I
    Int J Gynaecol Obstet; 2004 Jul; 86(1):52-3. PubMed ID: 15207678
    [No Abstract]   [Full Text] [Related]  

  • 27. Termination of early human pregnancy with RU 486 (mifepristone) and the prostaglandin analogue sulprostone: a multi-centre, randomized comparison between two treatment regimens.
    Bahzad C; Wyssling H; Saraya L; Shi YE; Prasad RN; Swahn ML; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Aug; 4(6):718-25. PubMed ID: 2778058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-trimester pregnancy termination with 800 microg of vaginal misoprostol every 12 h.
    Salakos N; Kountouris A; Botsis D; Rizos D; Gregoriou O; Detsis G; Creatsas G
    Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):249-54. PubMed ID: 16448952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interruptio - conventional or drug induced? A report on 58 abortions using intramuscular injections of sulproston].
    Schlüter K; Haensel W; Stolte M; Stampehl B
    Med Welt; 1980 Mar; 31(10):370-3. PubMed ID: 7392910
    [No Abstract]   [Full Text] [Related]  

  • 30. Methotrexate and misoprostol for abortion.
    Med Lett Drugs Ther; 1996 Apr; 38(973):39-40. PubMed ID: 8602122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Methotrexate and misoprostol for drug-induced abortion in the first trimester].
    Wolff F
    Dtsch Med Wochenschr; 1995 Dec; 120(51-52):1804. PubMed ID: 8549271
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma levels of SP1-like immunoreactive material (SP1) and progesterone throughout pregnancy and following RU 486-induced early abortion in the cynomolgus monkey (Macaca fascicularis).
    Germain G; Mignot T; Bischof P; Mouren M; Cédard L
    Hum Reprod; 1989 Nov; 4(8):975-80. PubMed ID: 2693485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The possible deleterious effects of the intramyometrial injection of hypertonic urea.
    Parmley TH; Burnett LS; Blake DA; Miyasaki BC; King TM
    Obstet Gynecol; 1976 Feb; 47(2):210-2. PubMed ID: 814512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion.
    Creinin MD; Vittinghoff E; Galbraith S; Klaisle C
    Am J Obstet Gynecol; 1995 Nov; 173(5):1578-84. PubMed ID: 7503204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experiences with sulproston for cervical priming in pregnancy termination in the 1st trimester].
    Heinzl S; Winkler C; Allemann F
    Gynakol Rundsch; 1982; 22(4):233-40. PubMed ID: 7160659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination.
    Guix C; Palacio M; Figueras F; Bennasar M; Zamora L; Coll O; Cararach V
    Fetal Diagn Ther; 2005; 20(6):544-8. PubMed ID: 16260893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised trial of two regimens of vaginal misoprostol to manage termination of pregnancy of up to 16 weeks.
    Khazardoost S; Hantoushzadeh S; Madani MM
    Aust N Z J Obstet Gynaecol; 2007 Jun; 47(3):226-9. PubMed ID: 17550491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prostaglandins for termination of pregnancy in the 2d and 3d trimester].
    Mursch G; Kassowitz C; Arzt W; Fröhlich H
    Geburtshilfe Frauenheilkd; 1988 Dec; 48(12):893-5. PubMed ID: 3234717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of terminating biochemical pregnancy and early clinical pregnancy with mifepristone and misoprostol].
    Li CL; Wei M; Fu MF; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):542-5. PubMed ID: 17983494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced termination of pregnancy by purified extracts of Azadirachta Indica (Neem): mechanisms involved.
    Talwar GP; Shah S; Mukherjee S; Chabra R
    Am J Reprod Immunol; 1997 Jun; 37(6):485-91. PubMed ID: 9228306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.